BioPharmaTrend
News
All Topics
  • AI in Bio
  • Tech Giants
  • Next-Gen Tools
  • Biotech Ventures
  • Industry Movers
  • NeuroTech
  • Interviews
  • Business Intelligence
  • Case Studies
Intelligence
  • Business Intelligence
  • Case Studies
  • Lab
  • Membership
About
  • At a Glance
  • Our Team
  • Advisory Board
  • Citations and Press Coverage
  • Partner Events Calendar
  • Advertise with Us
  • Write for Us
Newsletter
Login/Join
  • AI in Bio
  • Tech Giants
  • Next-Gen Tools
  • Biotech Ventures
  • Industry Movers
  • NeuroTech
This company is included in Intelligence Lab

Zapata Computing

Zapata Computing logo

Website
http://www.zapatacomputing.com
Founded
2017

Technologies

Quantum Theory in Drug Discovery

Our scientists help industry-leading companies understand — and capitalize on — the capabilities of quantum computing today, and the possibilities of quantum computing tomorrow. With Fortune 100 and Global 1000 companies, we are developing solutions for a wide range of industries including chemistry, logistics, finance, oil and gas, aviation, pharmaceuticals and materials. Zapata's quantum platform Orquestra™ (Orquestra) combines a powerful software platform and quantum algorithm libraries to deliver real-world advances in computational power for applications — particularly in chemistry, machine learning, and optimization. Orquestra enables users to compose quantum workflows and orchestrate their execution across classical and quantum technologies.


Articles Mentioning This Company

13 Publicly Traded AI-driven Drug Discovery Companies

13 Biotechs Utilizing AI-based Research Platforms

June 18, 2024     Articles
According to our intelligence report, more than 450 life sciences companies in the categories "startups" and "scaleups" are actively using machine learning and deep learning-based predictive and generative capabilities to augment their research strategies.  Some companies are incorporating AI tools to improve specific stages of drug discovery and development, for …
14 Companies Using Quantum Theory For Drug Discovery (Including 2 Going Public)

14 Companies Using Quantum Theory To Accelerate Drug Discovery (Including 2 Going Public)

Feb. 24, 2024     Articles
(Updated: 24.02.2024) Molecular mechanics (MM) is a traditional computational approach when it comes to modeling in synthetic organic chemistry, medicinal chemistry, and versatile aspects of drug design. However, MM methods have significant limitations, for example, when used to study electron-based properties within the drug-receptor microenvironment. Quantum mechanical (QM) methods allow …

From Qubits to Cures: The Promise of Quantum Computing in Pharmaceutical Research and Development (a Realistic View)

April 27, 2023     Articles
In a recent announcement, Moderna and IBM unveiled their partnership aimed at utilizing cutting-edge technologies, such as artificial intelligence (AI) and quantum computing, to accelerate research in messenger RNA (mRNA) therapeutics and vaccines. This collaboration highlights the growing interest in the potential of quantum computing within the life sciences sector.

Merging AI and Quantum Computing To Boost Drug Discovery

April 26, 2022     Interviews
Quantum computing is a growing trend due to recent major advances in hardware making this technology a practically feasible thing. Some experts compare today’s rapid progress in quantum computing with a similar period during the last century when personal computing was emerging through a cascade of technological advances both in …

News

  • 2024-02-22
    Using Quantum-Enhanced AI to Design Novel KRAS Inhibitors

BiopharmaTrend.com

Where Tech Meets Bio
mail  Newsletter
in  LinkedIn
x  X
rss  RSS Feed

About


  • What we do
  • Citations and Press Coverage
  • Terms of Use
  • Privacy Policy
  • Disclaimer

We Offer


  • Newsletter
  • Business Intelligence
  • Interviews
  • Partner Events
  • Case Studies

Opportunities


  • Advertise
  • Lab Access
  • Lab Membership
  • Write for Us
  • Contact Us

© BPT Analytics LTD 2025
We use cookies to personalise content and to analyse our traffic. You consent to our cookies if you continue to use our website. Read more details in our cookies policy.